Skip to content
OpenCapital
Get started

Microbot Medical MBOT Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$47.13+56.3%
Espey Manufacturing & Electronics Corp. logo
Espey Manufacturing & Electronics Corp.ESP
5.4+13.4%
CB Financial Services logo
CB Financial ServicesCBFV
$22.65-0.4%
Microbot Medical logo
Microbot MedicalMBOT
$1.65+66.7%
WaFd, Inc. logo
WaFd, Inc.WAFD
$7.53+36.9%
American Battery Technology Company logo
American Battery Technology CompanyABAT
$1.90—

Other financials

Income statement

See full
Revenue$105.0K—
Gross profit$2.0K—
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×—

Profitability

See full
Operating margin25,292.9%—
Net margin-3,669.9%—
FCF margin-852.8%—

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0×0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?
Microbot Medical (MBOT) reported share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price of $1.65 in Q4 2025.
What is the long-term trend for Microbot Medical's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price?
Over 3 years (2022 to 2025), Microbot Medical's share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price has grown at a -28.4% compound annual growth rate (CAGR), from $4.50 to $1.65.
What does share-based compensation arrangement by share-based payment award, option, nonvested, weighted average exercise price mean?
The weighted average exercise price for outstanding non-vested share-based payment awards, such as stock options granted to employees or consultants. This metric provides insight into the cost basis of equity incentives and the potential future dilution for shareholders. It is a key indicator of the company's compensation strategy and alignment with long-term performance.